Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(9%)
Results Posted
11%(1 trials)

Phase Distribution

Ph phase_1
1
9%
Ph not_applicable
9
82%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Other(1)

Detailed Status

Completed9
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

unknown19%
completed982%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11